Medpace Holdings Cash on Hand 2014-2024 | MEDP

  • Medpace Holdings cash on hand for 2024 was $0.669B, a 172.74% increase from 2023.
  • Medpace Holdings cash on hand for 2023 was $0.245B, a 768.38% increase from 2022.
  • Medpace Holdings cash on hand for 2022 was $0.028B, a 93.87% decline from 2021.

Quarterly Chart

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$148.1B
Elevance Health (ELV)$90.8B
CVS Health (CVS)$83.7B
Cencora (COR)$47.6B
DiDi Global (DIDIY)$23.1B
Natera (NTRA)$22.8B
ICON (ICLR)$15.8B
Doximity (DOCS)$14.3B
BioMerieux (BMXMF)$14.1B
Revvity (RVTY)$14B
Viatris (VTRS)$13B
Solventum (SOLV)$12.8B
Avantor (AVTR)$12B
CochLear (CHEOY)$11.5B
HealthEquity (HQY)$9.9B
EUROFINS SCIENT (ERFSF)$9.5B
Sonic Healthcare (SKHHY)$8.8B
Charles River Laboratories (CRL)$8.4B
Amplifon S.p.A (AMFPF)$6.2B
Bausch + Lomb (BLCO)$5.7B
Organon (OGN)$3.9B
Sotera Health (SHC)$3.9B
BrightSpring Health Services (BTSG)$3.6B
Surgery Partners (SGRY)$3.3B
GeneDx Holdings (WGS)$3.1B
Concentras Parent (CON)$3B
Alignment Healthcare (ALHC)$2.7B
Teladoc Health (TDOC)$2.4B
Ardent Health Partners (ARDT)$2.1B
Progyny (PGNY)$2B